{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,27]],"date-time":"2026-10-27T23:01:37Z","timestamp":1793142097787,"version":"4.5.0"},"reference-count":64,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,4,1]],"date-time":"2024-04-01T00:00:00Z","timestamp":1711929600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,4,1]],"date-time":"2024-04-01T00:00:00Z","timestamp":1711929600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,4,1]],"date-time":"2024-04-01T00:00:00Z","timestamp":1711929600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2024,4,1]],"date-time":"2024-04-01T00:00:00Z","timestamp":1711929600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,4,1]],"date-time":"2024-04-01T00:00:00Z","timestamp":1711929600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2024,4,1]],"date-time":"2024-04-01T00:00:00Z","timestamp":1711929600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,4,1]],"date-time":"2024-04-01T00:00:00Z","timestamp":1711929600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.es","clinicalkey.com.au","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Affective Disorders"],"published-print":{"date-parts":[[2024,4]]},"DOI":"10.1016\/j.jad.2024.01.197","type":"journal-article","created":{"date-parts":[[2024,1,26]],"date-time":"2024-01-26T11:42:01Z","timestamp":1706269321000},"page":"194-201","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":44,"special_numbering":"C","title":["Longitudinal associations between psychedelic use and psychotic symptoms in the United States and the United Kingdom"],"prefix":"10.1016","volume":"351","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-6174-3671","authenticated-orcid":false,"given":"Ludwig","family":"Honk","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8411-0666","authenticated-orcid":false,"given":"Cecilia U.D.","family":"Stenfors","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6888-0126","authenticated-orcid":false,"given":"Simon B.","family":"Goldberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter S.","family":"Hendricks","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1583-7319","authenticated-orcid":false,"given":"Walter","family":"Osika","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haley Maria","family":"Dourron","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0319-2357","authenticated-orcid":false,"given":"Alexander","family":"Lebedev","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Predrag","family":"Petrovic","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4197-7566","authenticated-orcid":false,"given":"Otto","family":"Simonsson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jad.2024.01.197_bb0005","article-title":"96. An open label study of synthetic psilocybin in bipolar type ii depression","volume":"93(9, Supplement), S132-S133","author":"Aaronson","year":"2023","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.jad.2024.01.197_bb0010","article-title":"Single-dose synthetic psilocybin with psychotherapy for treatment-resistant bipolar type ii major depressive episodes: a nonrandomized controlled trial","author":"Aaronson","year":"2023","journal-title":"JAMA Psychiatry"},{"issue":"12","key":"10.1016\/j.jad.2024.01.197_bb0020","doi-asserted-by":"crossref","first-page":"892","DOI":"10.1176\/appi.ajp.22010073","article-title":"A case of prolonged mania, psychosis, and severe depression after psilocybin use: implications of increased psychedelic drug availability","volume":"179","author":"Barber","year":"2022","journal-title":"Am. J. Psychiatry"},{"issue":"3","key":"10.1016\/j.jad.2024.01.197_bb0030","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1177\/0269881114565144","article-title":"Psilocybin-assisted treatment for alcohol dependence: a proof-of-concept study","volume":"29","author":"Bogenschutz","year":"2015","journal-title":"J. Psychopharmacol."},{"issue":"10","key":"10.1016\/j.jad.2024.01.197_bb0035","doi-asserted-by":"crossref","first-page":"953","DOI":"10.1001\/jamapsychiatry.2022.2096","article-title":"Percentage of heavy drinking days following psilocybin-assisted psychotherapy vs placebo in the treatment of adult patients with alcohol use disorder: a randomized clinical trial","volume":"79","author":"Bogenschutz","year":"2022","journal-title":"JAMA Psychiatry"},{"issue":"1","key":"10.1016\/j.jad.2024.01.197_bb0040","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1186\/s40345-022-00265-5","article-title":"Psychedelics in the treatment of unipolar and bipolar depression","volume":"10","author":"Bosch","year":"2022","journal-title":"Int J Bipolar Disord"},{"issue":"2","key":"10.1016\/j.jad.2024.01.197_bb0045","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1016\/j.genm.2009.07.004","article-title":"Gender differences in psychotic bipolar mania","volume":"6","author":"Br\u00e4unig","year":"2009","journal-title":"Gend. Med."},{"issue":"12","key":"10.1016\/j.jad.2024.01.197_bb0055","doi-asserted-by":"crossref","first-page":"1268","DOI":"10.1177\/0269881116662634","article-title":"Survey study of challenging experiences after ingesting psilocybin mushrooms: acute and enduring positive and negative consequences","volume":"30","author":"Carbonaro","year":"2016","journal-title":"J. Psychopharmacol."},{"issue":"15","key":"10.1016\/j.jad.2024.01.197_bb0065","doi-asserted-by":"crossref","first-page":"1402","DOI":"10.1056\/NEJMoa2032994","article-title":"Trial of psilocybin versus escitalopram for depression","volume":"384","author":"Carhart-Harris","year":"2021","journal-title":"N. Engl. J. Med."},{"issue":"4","key":"10.1016\/j.jad.2024.01.197_bb0075","doi-asserted-by":"crossref","DOI":"10.3390\/jpm12040615","article-title":"Antidepressant treatment and manic switch in bipolar i disorder: a clinical and molecular genetic study","volume":"12","author":"Chen","year":"2022","journal-title":"J. Pers. Med."},{"issue":"2","key":"10.1016\/j.jad.2024.01.197_bb0085","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1016\/j.biopsych.2019.10.015","article-title":"The genetics of the mood disorder spectrum: genome-wide association analyses of more than 185,000 cases and 439,000 controls","volume":"88","author":"Coleman","year":"2020","journal-title":"Biol. Psychiatry"},{"issue":"5","key":"10.1016\/j.jad.2024.01.197_bb0090","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1001\/jamapsychiatry.2020.3285","article-title":"Effects of psilocybin-assisted therapy on major depressive disorder: a randomized clinical trial","volume":"78","author":"Davis","year":"2021","journal-title":"JAMA Psychiatry"},{"issue":"12","key":"10.1016\/j.jad.2024.01.197_bb0095","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0279073","article-title":"\u201ca sense of the bigger picture:\u201d a qualitative analysis of follow-up interviews with people with bipolar disorder who self-reported psilocybin use","volume":"17","author":"DellaCrosse","year":"2022","journal-title":"PLoS One"},{"issue":"4","key":"10.1016\/j.jad.2024.01.197_bb0100","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1177\/2045125316689030","article-title":"Ayahuasca, dimethyltryptamine, and psychosis: a systematic review of human studies","volume":"7","author":"Dos Santos","year":"2017","journal-title":"Ther. Adv. Psychopharmacol."},{"issue":"10","key":"10.1016\/j.jad.2024.01.197_bb0105","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0293349","article-title":"Extended difficulties following the use of psychedelic drugs: a mixed methods study","volume":"18","author":"Evans","year":"2023","journal-title":"PLoS One"},{"key":"10.1016\/j.jad.2024.01.197_bb0110","article-title":"Substance-induced psychoses: an updated literature review","volume":"12","author":"Fiorentini","year":"2021","journal-title":"Front. Psychol."},{"issue":"5","key":"10.1016\/j.jad.2024.01.197_bb0115","doi-asserted-by":"crossref","first-page":"2338","DOI":"10.1073\/pnas.1918477117","article-title":"Transformative experience and social connectedness mediate the mood-enhancing effects of psychedelic use in naturalistic settings","volume":"117","author":"Forstmann","year":"2020","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"5","key":"10.1016\/j.jad.2024.01.197_bb0120","doi-asserted-by":"crossref","first-page":"592","DOI":"10.1177\/13634615221129116","article-title":"Psychosis and psychedelics: historical entanglements and contemporary contrasts","volume":"59","author":"Friesen","year":"2022","journal-title":"Transcult. Psychiatry"},{"key":"10.1016\/j.jad.2024.01.197_bb0125","article-title":"Evaluating the risk of psilocybin for the treatment of bipolar depression: a review of the research literature and published case studies","volume":"6","author":"Gard","year":"2021","journal-title":"J. Affect. Disorders Rep."},{"issue":"18","key":"10.1016\/j.jad.2024.01.197_bb0130","doi-asserted-by":"crossref","first-page":"1637","DOI":"10.1056\/NEJMoa2206443","article-title":"Single-dose psilocybin for a treatment-resistant episode of major depression","volume":"387","author":"Goodwin","year":"2022","journal-title":"N. Engl. J. Med."},{"issue":"12","key":"10.1016\/j.jad.2024.01.197_bb0135","doi-asserted-by":"crossref","first-page":"1181","DOI":"10.1177\/0269881116675513","article-title":"Psilocybin produces substantial and sustained decreases in depression and anxiety in patients with life-threatening cancer: a randomized double-blind trial","volume":"30","author":"Griffiths","year":"2016","journal-title":"J. Psychopharmacol."},{"issue":"5","key":"10.1016\/j.jad.2024.01.197_bb0140","doi-asserted-by":"crossref","first-page":"652","DOI":"10.1177\/1363461520983684","article-title":"Psychedelics, placebo effects, and set and setting: insights from common factors theory of psychotherapy","volume":"59","author":"Gukasyan","year":"2022","journal-title":"Transcult. Psychiatry"},{"key":"10.1016\/j.jad.2024.01.197_bb0145","doi-asserted-by":"crossref","first-page":"897","DOI":"10.3389\/fphar.2018.00897","article-title":"Predicting responses to psychedelics: a prospective study","volume":"9","author":"Haijen","year":"2018","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.jad.2024.01.197_bb0150","first-page":"1221131","article-title":"Manic episode following psilocybin use in a man with bipolar ii disorder: a case report","volume":"14","author":"Halim","year":"2023","journal-title":"Front. Psychol."},{"issue":"6","key":"10.1016\/j.jad.2024.01.197_bb0160","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1177\/0269881108093587","article-title":"Human hallucinogen research: guidelines for safety","volume":"22","author":"Johnson","year":"2008","journal-title":"J. Psychopharmacol."},{"issue":"4","key":"10.1016\/j.jad.2024.01.197_bb0165","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1017\/S0033291715002329","article-title":"Cannabis use and transition to psychosis in individuals at ultra-high risk: review and meta-analysis","volume":"46","author":"Kraan","year":"2016","journal-title":"Psychol. Med."},{"issue":"8","key":"10.1016\/j.jad.2024.01.197_bb0170","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0063972","article-title":"Psychedelics and mental health: a population study","volume":"8","author":"Krebs","year":"2013","journal-title":"PLoS One"},{"issue":"9","key":"10.1016\/j.jad.2024.01.197_bb0175","article-title":"The use of psychedelics in the treatment of medical conditions: an analysis of currently registered psychedelics studies in the american drug trial registry","volume":"14","author":"Kurtz","year":"2022","journal-title":"Cureus"},{"issue":"6","key":"10.1016\/j.jad.2024.01.197_bb0180","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1111\/j.1600-0447.2010.01633.x","article-title":"Associations between use of cocaine, amphetamines, or psychedelics and psychotic symptoms in a community sample","volume":"123","author":"Kuzenko","year":"2011","journal-title":"Acta Psychiatr. Scand."},{"issue":"1","key":"10.1016\/j.jad.2024.01.197_bb0185","doi-asserted-by":"crossref","first-page":"15058","DOI":"10.1038\/s41598-021-94421-z","article-title":"Psychedelic drug use and schizotypy in young adults","volume":"11","author":"Lebedev","year":"2021","journal-title":"Sci. Rep."},{"issue":"3","key":"10.1016\/j.jad.2024.01.197_bb0190","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1056\/NEJMra1801490","article-title":"Psychotic disorders","volume":"379","author":"Lieberman","year":"2018","journal-title":"N. Engl. J. Med."},{"issue":"12","key":"10.1016\/j.jad.2024.01.197_bb0195","doi-asserted-by":"crossref","first-page":"3099","DOI":"10.1111\/add.15987","article-title":"Adolescent and adult time trends in us hallucinogen use, 2002-19: any use, and use of ecstasy, lsd and pcp","volume":"117","author":"Livne","year":"2022","journal-title":"Addiction"},{"issue":"1","key":"10.1016\/j.jad.2024.01.197_bb0210","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1177\/02698811221131997","article-title":"Risks and benefits of psilocybin use in people with bipolar disorder: an international web-based survey on experiences of \u2018magic mushroom\u2019 consumption","volume":"37","author":"Morton","year":"2023","journal-title":"J. Psychopharmacol."},{"issue":"2","key":"10.1016\/j.jad.2024.01.197_bb0215","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1124\/pr.115.011478","article-title":"Psychedelics","volume":"68","author":"Nichols","year":"2016","journal-title":"Pharmacol. Rev."},{"issue":"4","key":"10.1016\/j.jad.2024.01.197_bb0220","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1055\/a-1310-3990","article-title":"The history of psychedelics in psychiatry","volume":"54","author":"Nichols","year":"2021","journal-title":"Pharmacopsychiatry"},{"issue":"1","key":"10.1016\/j.jad.2024.01.197_bb0225","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1089\/psymed.2022.0008","article-title":"Proposed consensus statement on defining psychedelic drugs","volume":"1","author":"Nichols","year":"2022","journal-title":"Psychedelic Med."},{"issue":"2","key":"10.1016\/j.jad.2024.01.197_bb0230","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1001\/jamapsychiatry.2020.2171","article-title":"The current status of psychedelics in psychiatry","volume":"78","author":"Nutt","year":"2021","journal-title":"JAMA Psychiatry"},{"issue":"8","key":"10.1016\/j.jad.2024.01.197_bb0235","doi-asserted-by":"crossref","first-page":"932","DOI":"10.1177\/02698811221101061","article-title":"Antidepressant effects of a psychedelic experience in a large prospective naturalistic sample","volume":"36","author":"Nygart","year":"2022","journal-title":"J. Psychopharmacol."},{"issue":"4","key":"10.1016\/j.jad.2024.01.197_bb0240","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1017\/S0033291718001356","article-title":"Rapid antidepressant effects of the psychedelic ayahuasca in treatment-resistant depression: a randomized placebo-controlled trial","volume":"49","author":"Palhano-Fontes","year":"2019","journal-title":"Psychol. Med."},{"issue":"12","key":"10.1016\/j.jad.2024.01.197_bb0245","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2015-008341","article-title":"Do antidepressants increase the risk of mania and bipolar disorder in people with depression? A retrospective electronic case register cohort study","volume":"5","author":"Patel","year":"2015","journal-title":"BMJ Open"},{"key":"10.1016\/j.jad.2024.01.197_bb0250","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/j.jesp.2017.01.006","article-title":"Beyond the turk: alternative platforms for crowdsourcing behavioral research","volume":"70","author":"Peer","year":"2017","journal-title":"J. Exp. Soc. Psychol."},{"issue":"4","key":"10.1016\/j.jad.2024.01.197_bb0255","doi-asserted-by":"crossref","first-page":"1643","DOI":"10.3758\/s13428-021-01694-3","article-title":"Data quality of platforms and panels for online behavioral research","volume":"54","author":"Peer","year":"2022","journal-title":"Behav. Res. Methods"},{"key":"10.1016\/j.jad.2024.01.197_bb0260","article-title":"Effects of naturalistic psychedelic use on depression, anxiety, and well-being: associations with patterns of use, reported harms, and transformative mental states","volume":"13","author":"Raison","year":"2022","journal-title":"Front. Psychol."},{"issue":"3","key":"10.1016\/j.jad.2024.01.197_bb0270","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1093\/biomet\/63.3.581","article-title":"Inference and missing data","volume":"63","author":"Rubin","year":"1976","journal-title":"Biometrika"},{"issue":"3","key":"10.1016\/j.jad.2024.01.197_bb0280","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1177\/02698811211069100","article-title":"Adverse effects of psychedelics: from anecdotes and misinformation to systematic science","volume":"36","author":"Schlag","year":"2022","journal-title":"J. Psychopharmacol."},{"issue":"1","key":"10.1016\/j.jad.2024.01.197_bb0285","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/j.jbtep.2004.02.002","article-title":"Factor structure of the psychiatric diagnostic screening questionnaire (pdsq), a screening questionnaire for dsm-iv axis i disorders","volume":"35","author":"Sheeran","year":"2004","journal-title":"J. Behav. Ther. Exp. Psychiatry"},{"key":"10.1016\/j.jad.2024.01.197_bb0290","doi-asserted-by":"crossref","DOI":"10.1007\/s00213-023-06478-5","article-title":"Psychedelic use and psychiatric risks","author":"Simonsson","year":"2023","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.jad.2024.01.197_bb0295","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/j.jad.2023.01.073","article-title":"Prevalence and associations of challenging, difficult or distressing experiences using classic psychedelics","volume":"326","author":"Simonsson","year":"2023","journal-title":"J. Affect. Disord."},{"key":"10.1016\/j.jad.2024.01.197_bb0300","article-title":"Longitudinal associations between psychedelic use and meditation practices in the United States and the United Kingdom","volume":"1-7","author":"Simonsson","year":"2023","journal-title":"Psychol. Med."},{"key":"10.1016\/j.jad.2024.01.197_bb0305","article-title":"Psilocybin-assisted therapy for major depressive disorder: an exploratory placebo-controlled, fixed-order trial","volume":"2698811231154852","author":"Sloshower","year":"2023","journal-title":"J. Psychopharmacol."},{"issue":"11","key":"10.1016\/j.jad.2024.01.197_bb0310","doi-asserted-by":"crossref","first-page":"1642","DOI":"10.1176\/ajp.151.11.1642","article-title":"Antidepressant-associated mania: a controlled comparison with spontaneous mania","volume":"151","author":"Stoll","year":"1994","journal-title":"Am. J. Psychiatry"},{"issue":"10","key":"10.1016\/j.jad.2024.01.197_bb0315","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1097\/00005053-198410000-00001","article-title":"Adverse reactions to psychedelic drugs. A review of the literature","volume":"172","author":"Strassman","year":"1984","journal-title":"J. Nerv. Ment. Dis."},{"issue":"10","key":"10.1016\/j.jad.2024.01.197_bb0320","doi-asserted-by":"crossref","first-page":"1472","DOI":"10.4088\/JCP.v68n1002","article-title":"Self-reported history of manic\/hypomanic switch associated with antidepressant use: data from the systematic treatment enhancement program for bipolar disorder (step-bd)","volume":"68","author":"Truman","year":"2007","journal-title":"J. Clin. Psychiatry"},{"key":"10.1016\/j.jad.2024.01.197_bb0325","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1186\/s12888-016-1002-7","article-title":"Psychosis associated with acute recreational drug toxicity: a european case series","volume":"16","author":"Vallersnes","year":"2016","journal-title":"BMC Psychiatry"},{"issue":"3","key":"10.1016\/j.jad.2024.01.197_bb0330","first-page":"1","article-title":"Mice: multivariate imputation by chained equations in r","volume":"45","author":"van Buuren","year":"2011","journal-title":"J. Stat. Softw."},{"key":"10.1016\/j.jad.2024.01.197_bb0335","doi-asserted-by":"crossref","first-page":"18008","DOI":"10.1038\/nrdp.2018.8","volume":"4","author":"Vieta","year":"2018","journal-title":"Bipolar disorders. Nat Rev Dis Primers"},{"key":"10.1016\/j.jad.2024.01.197_bb0340","article-title":"Single-dose psilocybin-assisted therapy in major depressive disorder: a placebo-controlled, double-blind, randomised clinical trial","volume":"56","author":"von Rotz","year":"2023","journal-title":"EClinicalMedicine"},{"key":"10.1016\/j.jad.2024.01.197_bb0345","series-title":"Could Psychedelic Drugs Have a Role in the Treatment of Schizophrenia?","author":"Wolf","year":"2022"},{"issue":"10","key":"10.1016\/j.jad.2024.01.197_bb0350","doi-asserted-by":"crossref","first-page":"943","DOI":"10.1001\/jamapsychiatry.2022.2546","article-title":"Preparing for the bursting of the psychedelic hype bubble","volume":"79","author":"Yaden","year":"2022","journal-title":"JAMA Psychiatry"},{"issue":"11","key":"10.1016\/j.jad.2024.01.197_bb0355","doi-asserted-by":"crossref","first-page":"1601","DOI":"10.1017\/S0033291706008257","article-title":"A scale to screen for dsm-iv axis i disorders in psychiatric out-patients: performance of the psychiatric diagnostic screening questionnaire","volume":"36","author":"Zimmerman","year":"2006","journal-title":"Psychol. Med."},{"issue":"3","key":"10.1016\/j.jad.2024.01.197_bb0360","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1016\/j.jpsychires.2005.03.001","article-title":"Screening for anxiety disorders in depressed patients","volume":"40","author":"Zimmerman","year":"2006","journal-title":"J. Psychiatr. Res."},{"issue":"8","key":"10.1016\/j.jad.2024.01.197_bb0365","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1001\/archpsyc.58.8.787","article-title":"A self-report scale to help make psychiatric diagnoses: the psychiatric diagnostic screening questionnaire","volume":"58","author":"Zimmerman","year":"2001","journal-title":"Arch. Gen. Psychiatry"},{"issue":"1","key":"10.1016\/j.jad.2024.01.197_bb0370","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1037\/1040-3590.15.1.110","article-title":"Screening for principal versus comorbid conditions in psychiatric outpatients with the psychiatric diagnostic screening questionnaire","volume":"15","author":"Zimmerman","year":"2003","journal-title":"Psychol. Assess."},{"issue":"1","key":"10.1016\/j.jad.2024.01.197_bb0375","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/S0165-0327(03)00050-8","article-title":"An illustration of how a self-report diagnostic screening scale could improve the internal validity of antidepressant efficacy trials","volume":"80","author":"Zimmerman","year":"2004","journal-title":"J. Affect. Disord."}],"container-title":["Journal of Affective Disorders"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0165032724002180?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0165032724002180?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,7,4]],"date-time":"2024-07-04T02:51:14Z","timestamp":1720061474000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0165032724002180"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,4]]},"references-count":64,"alternative-id":["S0165032724002180"],"URL":"https:\/\/doi.org\/10.1016\/j.jad.2024.01.197","relation":{},"ISSN":["0165-0327"],"issn-type":[{"value":"0165-0327","type":"print"}],"subject":[],"published":{"date-parts":[[2024,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Longitudinal associations between psychedelic use and psychotic symptoms in the United States and the United Kingdom","name":"articletitle","label":"Article Title"},{"value":"Journal of Affective Disorders","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jad.2024.01.197","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Published by Elsevier B.V.","name":"copyright","label":"Copyright"}]}}